These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28983119)

  • 1. The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p.
    Straniero L; Rimoldi V; Samarani M; Goldwurm S; Di Fonzo A; Krüger R; Deleidi M; Aureli M; Soldà G; Duga S; Asselta R
    Sci Rep; 2017 Oct; 7(1):12702. PubMed ID: 28983119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic variation in the CpG island of pseudogene GBAP1 promoter is associated with gastric cancer susceptibility.
    Ma G; Liu H; Du M; Zhang G; Lin Y; Ge Y; Wang M; Jin G; Zhao Q; Chu H; Gong W; Zhang Z
    Cancer; 2019 Jul; 125(14):2465-2473. PubMed ID: 30951202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The annotation of
    Gustavsson EK; Sethi S; Gao Y; Brenton JW; García-Ruiz S; Zhang D; Garza R; Reynolds RH; Evans JR; Chen Z; Grant-Peters M; Macpherson H; Montgomery K; Dore R; Wernick AI; Arber C; Wray S; Gandhi S; Esselborn J; Blauwendraat C; Douse CH; Adami A; Atacho DAM; Kouli A; Quaegebeur A; Barker RA; Englund E; Platt F; Jakobsson J; Wood NW; Houlden H; Saini H; Bento CF; Hardy J; Ryten M
    Sci Adv; 2024 Jun; 10(26):eadk1296. PubMed ID: 38924406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining GBA gene structure unveils the ability of Cap-independent, IRES-dependent gene regulation.
    Miyoshi K; Hagita H; Horiguchi T; Tanimura A; Noma T
    Commun Biol; 2022 Jul; 5(1):639. PubMed ID: 35831491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort.
    Graham OEE; Pitcher TL; Liau Y; Miller AL; Dalrymple-Alford JC; Anderson TJ; Kennedy MA
    Parkinsonism Relat Disord; 2020 Jan; 70():36-41. PubMed ID: 31809948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson's disease-associated GBA gene.
    Toffoli M; Chen X; Sedlazeck FJ; Lee CY; Mullin S; Higgins A; Koletsi S; Garcia-Segura ME; Sammler E; Scholz SW; Schapira AHV; Eberle MA; Proukakis C
    Commun Biol; 2022 Jul; 5(1):670. PubMed ID: 35794204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
    Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
    Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems.
    Baden P; Yu C; Deleidi M
    Neurobiol Dis; 2019 Jul; 127():1-12. PubMed ID: 30711484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications.
    Balestrino R; Schapira AHV
    Neuroscientist; 2018 Oct; 24(5):540-559. PubMed ID: 29400127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Pchelina S; Emelyanov A; Baydakova G; Andoskin P; Senkevich K; Nikolaev M; Miliukhina I; Yakimovskii A; Timofeeva A; Fedotova E; Abramycheva N; Usenko T; Kulabukhova D; Lavrinova A; Kopytova A; Garaeva L; Nuzhnyi E; Illarioshkin S; Zakharova E
    Neurosci Lett; 2017 Jan; 636():70-76. PubMed ID: 27780739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GBA mutations and Parkinson's disease].
    Wang DX; Xie JX; Song N
    Sheng Li Xue Bao; 2018 Jun; 70(3):294-300. PubMed ID: 29926071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the glucocerebrosidase gene in Parkinson's disease.
    Sato C; Morgan A; Lang AE; Salehi-Rad S; Kawarai T; Meng Y; Ray PN; Farrer LA; St George-Hyslop P; Rogaeva E
    Mov Disord; 2005 Mar; 20(3):367-70. PubMed ID: 15517592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of patient-derived pluripotent stem cell-lines and CRISPR modified isogenic controls with mutations in the Parkinson's associated GBA gene.
    X-Q Chen C; Deneault E; Abdian N; You Z; Sirois J; Nicouleau M; Shlaifer I; Villegas L; Boivin MN; Gaborieau L; Karamchandani J; Beitel LK; Fon EA; Durcan TM
    Stem Cell Res; 2022 Oct; 64():102919. PubMed ID: 36130446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and analysis of a lncRNA (PWRN2)-mediated ceRNA network reveal its potential roles in oocyte nuclear maturation of patients with PCOS.
    Huang X; Pan J; Wu B; Teng X
    Reprod Biol Endocrinol; 2018 Aug; 16(1):73. PubMed ID: 30075721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase pseudogene variation and Gaucher disease: Recognizing pseudogene tracts in GBA alleles.
    Martínez-Arias R; Comas D; Mateu E; Bertranpetit J
    Hum Mutat; 2001 Mar; 17(3):191-8. PubMed ID: 11241841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.